Skip to Main Content

Paper Details

Trastuzumab-based regimens beyond progression: A crucial treatment option for HER2+ advanced/metastatic breast cancer.
Breast
2
2022
Author NameAffiliation
Fatima CardosoChampalimaud Clinical Center/Champalimaud Foundation and ABC Global Alliance
  • 1 - 1

Datasets

Release 1.2